Novo Nordisk shares dip as Wegovy maker posts earnings miss, cuts operating profit outlook

  • 📰 NBCPhiladelphia
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

News 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Novo Nordisk on Wednesday announced its second quarter earnings for 2024.

Novo Nordisk on Wednesday said its net profit came in at 20.05 billion Danish kroner in the second quarter of 2024, below forecasts.

EBIT — earnings before interest and tax — came in at 25.93 billion Danish kroner in the second quarter, which was also below the LSEG forecast of 26.86 billion Danish kroner.saying growth was now anticipated to come in between 20% and 28%, rather than the previously expected 22% to 30% range. Sales of popular weight loss drug Wegovy jumped 55% in the second quarter of 2024, compared to the same period in 2023, coming in at 11.66 billion kroner.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 569. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
출처: NBCLA - 🏆 319. / 59 더 많은 것을 읽으십시오 »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »

Shares of Wegovy maker Novo Nordisk slide 5% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
출처: NBCNewYork - 🏆 270. / 63 더 많은 것을 읽으십시오 »

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »